10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 150,158 | $13,478,364 | +2% | 2.9% |
| 2. | Lee Munder Capital Group Lee Munder | 112,616 | $10,108,412 | -2% | 0.67% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | Director | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | Director | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | Officer | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | Officer | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | Officer | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.09 | 8,500 | Officer | 30,705 | 2025-02-19 | Filing | |
| $85.34 | 6,000 | Officer | 24,123 | 2025-02-13 | Filing | |
| $88.76 | 2,361 | Officer | 7,085 | 2025-02-06 | Filing | |
| $125.50 | 38,291 | Officer | 50,908 | 2024-02-14 | Filing | |
| $125.40 | 85,021 | Officer, Director | 348,327 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,492,983 | $403,290,062 | 0.38% | |
| 2. | 1,884,285 | $213,979,409 | 2.06% | |
| 3. | Imc-chicago, LlcCALL | 893,000 | $80,155,680 | 0.05% |
| 4. | 647,298 | $57,758,401 | 4.47% | |
| 5. | 615,565 | $55,253,080 | 0.63% |
News See All
10 High Growth Forever Dividend Stocks To Invest In
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Jim Cramer Recently Talked About These 9 Stocks
On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the market turmoil of the week and provided some valuable lessons. He emphasized that no one ever made a profit by panicking.
11 Cheap NYSE Stocks to Invest in According to Hedge Funds
On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in a discussion on CNBC's 'Squawk Box'.
10 Best Medical Stocks to Buy According to Billionaires
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Merck & Co., Inc. (MRK): A Bull Case Theory
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
10 Defensive Stocks Billionaire Ken Fisher Is Betting On
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Jim Cramer Reveals How Markets Can Stabilize & Discusses These 8 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer shared what the Trump administration could do to stop the stock market bloodbath unleashed by tariffs.
Jim Cramer Recently Put These 10 Stocks Under Spotlight
On Monday, Jim Cramer, host of Mad Money, shared his thoughts on how the government's approach to tariffs could play a crucial role in sustaining the stock market rally.
10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher
Billionaire Ken Fisher, a prominent money manager, renowned author, and financial analyst, is the founder of Fisher Asset Management.
Billionaire Hedge Funds
